BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 312241)

  • 1. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute pharmacologic effects of serotonin on the release of insulin and glucagon in the intact rat.
    Jacoby JH; Bryce GF
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):254-70. PubMed ID: 310665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; El Halawani ME
    Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys.
    Witkin JM; Brady LS; Barrett JE
    Psychopharmacology (Berl); 1988; 94(3):302-5. PubMed ID: 3128804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine impairs insulin secretion without modifying extracellular serotonin levels in MIN6 β-cells.
    Cataldo LR; Cortés VA; Mizgier ML; Aranda E; Mezzano D; Olmos P; Galgani JE; Suazo J; Santos JL
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):473-8. PubMed ID: 26011169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat.
    Malec D; Langwinski R
    J Pharm Pharmacol; 1980 Jan; 32(1):71-3. PubMed ID: 6102137
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
    Rodríguez Echandía EL; Broitman ST; Fóscolo MR
    Pharmacol Biochem Behav; 1983 Aug; 19(2):193-7. PubMed ID: 6605538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quipazine-induced head-twitch in mice.
    Malick JB; Doren E; Barnett A
    Pharmacol Biochem Behav; 1977 Mar; 6(3):325-9. PubMed ID: 140381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonin autoreceptor: antagonism by quipazine.
    Martin LL; Sanders-Bush E
    Neuropharmacology; 1982 May; 21(5):445-50. PubMed ID: 6981071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.
    Alhaider AA; Mustafa AA
    Psychopharmacology (Berl); 1991; 103(3):351-6. PubMed ID: 1647538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical short-term effects of cyproheptadine on insulin and glucagon release in the rat.
    Bryce GF; Jacoby JH
    Eur J Pharmacol; 1979 Mar; 54(4):349-57. PubMed ID: 436934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence that the central serotoninergic system plays a role in the activation of prolactin secretion following inhibition of dopamine synthesis or blockade of dopamine receptors in the male rat.
    Krulich L; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Neuroendocrinology; 1980; 30(3):133-8. PubMed ID: 6445044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of pharmacological manipulation of serotonin on serum growth hormone and luteinizing hormone levels in young turkeys (Meleagris gallopavo).
    Fehrer SC; Silsby JL; Burke WH; el Halawani ME
    Poult Sci; 1985 Jul; 64(7):1356-62. PubMed ID: 3161015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different serotonin receptor types participate in 5-hydroxytryptophan-induced gonadotropins and prolactin release in the female infantile rat.
    Lacau-Mengido IM; Libertun C; Becú-Villalobos D
    Neuroendocrinology; 1996 May; 63(5):415-21. PubMed ID: 8738578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.